Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia

Journal of Clinical Oncology

Volumn 21, Issue 21, 2003, Pages 3928-3932

  Vasconcelos, Yuri ^a   Davi, Frédéric ^a   Levy, Vincent ^a   Oppezzo, Pablo ^a   Magnac, Christian ^a   Michel, Ariane ^a   Yamamoto, Mihoko ^a   Pritsch, Otto ^a   Merle Béral, Hélène ^a   Maloum, Karim ^a   Ajchenbaum Cymbalista, Florence ^a   Dighiero, Guillaume ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CHLORAMBUCIL; FLUDARABINE; IMMUNOGLOBULIN HEAVY CHAIN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; BRAZIL; DISEASE COURSE; DISEASE FREE SURVIVAL; EVALUATION; FRANCE; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; MALE; METHODOLOGY; MORTALITY; MUTATION; PATHOLOGY; SURVIVAL; TUMOR RECURRENCE; URUGUAY;

BRAZIL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FRANCE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; URUGUAY;

EID: 0642281445     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.02.134     Document Type: Article

References (21)

1. Moreau EJ, Matutes E, A'Hern RP, et al: Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol 108:378-382, 1997
2. Schroeder HW Jr, Dighiero G: The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today 15:288-294, 1994
3. Dighiero G, Maloum K, Desablens B, et al: Chlorambucil in indolent chronic lymphocytic leukemia: French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 338:1506-1514, 1998
4. Rai KR, Sawitsky A, Cronkite EP, et al: Clinical staging of chronic lymphocytic leukemia. Blood 46:219-234, 1975
5. Binet JL, Auquier A, Dighiero G, et al: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206, 1981
6. French Cooperative Group on Chronic Lymphocytic Leukemia: Natural history of stage A chronic lymphocytic leukemia untreated patients. Br J Haematol 76:45-57, 1990
7. Montserrat E, Vinolas N, Reverter JC, et al: Natural history of chronic lymphocytic leukemia: On the progression and progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 30:359-361, 1988
8. Damle RN, Wasil T, Fais F, et al: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-1847, 1999
9. Montserrat E: Classical and new prognostic factors in chronic lymphocytic leukemia: Where to now? Hematol J 3:7-9, 2002
10. Krober A, Seiler T, Benner A, et al: V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410-1416, 2002
11. Dohner H, Stilgenbauer S, Benner A, et al: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910-1916, 2000
12. Oscier DG, Gardiner AC, Mould SJ, et al: Multivariate analysis of prognostic factors in CLL: Clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 100:1177-1184, 2002
13. Hamblin TJ, Davis Z, Gardiner A, et al: Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854, 1999
14. Maloum K, Davi F, Merle-Beral H, et al: Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 96:377-379, 2000
15. French Cooperative Group on Chronic Lymphocytic Leukemia: Prognostic and therapeutic advances in CLL management: The experience of the French Cooperative Group. Semin Hematol 24:275-290, 1987
16. Cheson BD, Bennett JM, Grever M, et al: National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87:4990-4997, 1996
17. Pritsch O, Troussard X, Magnac C, et al: VH gene usage by family members affected with chronic lymphocytic leukaemia. Br J Haematol 107:616-624, 1999
18. Kaplan E, Meier P: Non parametric estimation for incomplete observations. J Am Stat Assoc 53:457-481, 1958
19. Tobin G, Thunberg U, Johnson A, et al: Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 99:2262-2264, 2002
20. Magnac C, Porcher R, Davi F, et al: Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. Leukemia 17:133-137, 2003
21. Orchard J, Ibbotson R, Davis Z, et al: Zap-70 evaluation by flow cytometry is a significant prognostic marker in B-CLL. Blood 100:168a, 2002 (abstr 630)